Is Gufic Biosciences Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Gufic Biosciences Ltd (GUFICBIO.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Gufic Biosciences Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Gufic Biosciences Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Gufic Biosciences Ltd?

Muslim investors may consider investing in Gufic Biosciences Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Gufic Biosciences Ltd classified as HALAL?

Musaffa determines the Shariah status of Gufic Biosciences Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Gufic Biosciences Ltd updated?

The Shariah compliance status of Gufic Biosciences Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Gufic Biosciences Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Gufic Biosciences Ltd?

You can check the latest Shariah compliance status of Gufic Biosciences Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

GUFICBIO.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 04, 2026

Report Source: 2026 3rd Quarter Report

Gufic Biosciences Ltd. Stock Analysis GUFICBIO.NS

India Health Care Small Cap Report: Q3, 2026

Gufic Biosciences Ltd. engages in the manufacture and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. The firm operates in the pharmaceutical segment. The company has pharmaceutical products under categories, such as Criti Care, including Doxific, Micafung, Rabol and Tigefic-Plus; Criticare Life, including Ticofic-200 and Gufivan-500; Ferticare, including Puregraf 75IU 3D, Cetrocare 0.25mg 3D and Follicare 150IU 3D; Spark, including Aznee Duo, Eclin, Flabone, Vipro M and Zad G; Herbal, including Bocomo-Forte, Sallaki-Liniment, Zulcer Cap and Smashit tablet, and Aesthaderm, including Prosil, Moiseta Face Wash and Revanox Serum. Its personal care products include StretchNil, Shapers-Natural Feel, Shaper-DryFeel and RollOn. Its products under active pharmaceutical ingredient (API)/bulk drugs include Micafungin, Anidulafungin, Sulconazole and Everolimus. Its Gufic Stridden includes Irvical and Eve.

Key Statistics of Gufic Biosciences Ltd (GUFICBIO.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹279.45₹292.50

Today's Open

₹286.10

Volume

44.95K

P/E Ratio (TTM)

41.41

52 Week Range

₹268.00₹407.85

Market Cap

29.32B

Avg. Volume

65.12K

Dividend Yield

Financial Metrics & Statements of Gufic Biosciences Ltd (GUFICBIO.NS)

FAQ's for Gufic Biosciences Ltd (GUFICBIO.NS)

According to Musaffa’s Shariah screening methodology, Gufic Biosciences Ltd (GUFICBIO.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.